Regeneron reports sustained efficacy for FOP treatment Pasatru
AI Summary
Regeneron reported sustained efficacy for Pasatru, a treatment for fibrodysplasia ossificans progressiva (FOP). The article provides no further trial details or data.
Regeneron reported sustained efficacy for Pasatru, a treatment for fibrodysplasia ossificans progressiva (FOP). The article provides no further trial details or data.
Punch Nigeria —
Punch Nigeria —
Punch Nigeria —
Globo —
Punch Nigeria —
Tehran Times —